Algert Global LLC Sarepta Therapeutics, Inc. Transaction History

Algert Global LLC

  • $4.04 Billion
  • Q1 2025

A detailed history of Algert Global LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Algert Global LLC holds 76,669 shares of SRPT stock, worth $1.38 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
76,669
Previous 74,984 2.25%
Holding current value
$1.38 Million
Previous $9.12 Million 46.33%
% of portfolio
0.12%
Previous 0.21%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
BUY
$63.82 - $127.89 $107,536 - $215,494
1,685 Added 2.25%
76,669 $4.89 Million
Q4 2024

Feb 14, 2025
BUY
$104.54 - $137.94 $604,032 - $797,017
5,778 Added 8.35%
74,984 $9.12 Million
Q3 2024

Nov 12, 2024
BUY
$124.33 - $156.75 $827,291 - $1.04 Million
6,654 Added 10.64%
69,206 $8.64 Million
Q2 2024

Aug 14, 2024
BUY
$113.33 - $163.85 $90,097 - $130,260
795 Added 1.29%
62,552 $9.88 Million
Q1 2024

May 14, 2024
BUY
$93.7 - $141.53 $1.43 Million - $2.16 Million
15,238 Added 32.76%
61,757 $8 Million
Q4 2023

Feb 14, 2024
BUY
$67.31 - $124.76 $224,613 - $416,324
3,337 Added 7.73%
46,519 $4.49 Million
Q3 2023

Nov 13, 2023
BUY
$102.5 - $123.59 $1.81 Million - $2.18 Million
17,670 Added 69.26%
43,182 $5.24 Million
Q2 2023

Aug 14, 2023
BUY
$106.4 - $157.19 $476,672 - $704,211
4,480 Added 21.3%
25,512 $2.92 Million
Q1 2023

May 12, 2023
SELL
$117.53 - $155.99 $3.67 Million - $4.87 Million
-31,212 Reduced 59.74%
21,032 $2.9 Million
Q4 2022

Feb 13, 2023
SELL
$100.86 - $132.13 $849,846 - $1.11 Million
-8,426 Reduced 13.89%
52,244 $6.77 Million
Q3 2022

Nov 15, 2022
BUY
$75.71 - $119.24 $1.32 Million - $2.08 Million
17,479 Added 40.47%
60,670 $6.71 Million
Q2 2022

Aug 15, 2022
SELL
$62.69 - $88.44 $238,974 - $337,133
-3,812 Reduced 8.11%
43,191 $3.24 Million
Q1 2022

May 16, 2022
BUY
$63.15 - $90.42 $2.09 Million - $2.99 Million
33,066 Added 237.25%
47,003 $3.67 Million
Q3 2021

Nov 15, 2021
BUY
$65.97 - $92.48 $919,423 - $1.29 Million
13,937 New
13,937 $1.29 Million
Q3 2020

Nov 16, 2020
SELL
$127.12 - $172.34 $780,262 - $1.06 Million
-6,138 Closed
0 $0
Q2 2020

Aug 12, 2020
BUY
$93.0 - $171.7 $570,834 - $1.05 Million
6,138 New
6,138 $984,000

Others Institutions Holding SRPT

# of Institutions
489
Shares Held
91.1M
Call Options Held
1.39M
Put Options Held
1.15M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $1.57B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email